<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04921501</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX 2020/59</org_study_id>
    <nct_id>NCT04921501</nct_id>
  </id_info>
  <brief_title>Evaluation of Electrocardiographic Measurements by High Density Electrode ECG (ECG-HD)</brief_title>
  <acronym>ECG-HD</acronym>
  <official_title>Evaluation of Electrocardiographic Measurements by High Density Electrode ECG (ECG-HD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiac electrical activity is detected on the body surface with conventional&#xD;
      electrocardiography involving 12 leads (ECG 12). A limitation of the current ECG technique is&#xD;
      that recordings are obtained from only 6 independent precordial leads pairs ; which may miss&#xD;
      cardiac potentials from spatially limited regions. More extensive sampling of the body&#xD;
      surface may contribute to additional clinical information. The present study investigates the&#xD;
      additional sensitivity of ECG using 128 body surface leads (High Density (HD) ECG) in&#xD;
      measuring global or regional cardiac activity.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 6, 2021</start_date>
  <completion_date type="Anticipated">April 2026</completion_date>
  <primary_completion_date type="Anticipated">April 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Prospective single arm monocentric descriptive and evaluation study.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Identification of the &quot;amplitude&quot; electrical criteria by HD ECG</measure>
    <time_frame>Day 0</time_frame>
    <description>These electrical criteria are measured in millivolt (mV)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Identification of the &quot;cardiac time&quot; electrical criteria by HD ECG</measure>
    <time_frame>Day 0</time_frame>
    <description>Defined by the auricular cardiac time, ventricular depolarization and repolarization time</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Identification of the &quot;duration&quot; electrical criteria by HD ECG</measure>
    <time_frame>Day 0</time_frame>
    <description>These criteria are measured in milliseconds (ms)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Identification of &quot;anatomical locations&quot; electrical criteria by HD ECG</measure>
    <time_frame>Day 0</time_frame>
    <description>Defined by the position of the electrodes</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Ventricular Arrhythmias</condition>
  <arm_group>
    <arm_group_label>Proven or suspected arrhythmias group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HD ECG</intervention_name>
    <description>This experimental procedure is a passive, non-invasive, high-density surface ECG recording using 128 skin electrodes.The electrodes are positioned on strips of 10 electrodes to be prepared with adhesive tape and coated with conductive gel before installation on the patient. The total duration of the acquisition is 10 to 30 minutes.</description>
    <arm_group_label>Proven or suspected arrhythmias group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Conventional 12-lead ECG</intervention_name>
    <description>This standard 12-lead ECG is defined on the HD ECG, from electrodes F13, G3, G14, H5, H15, H25 corresponding to the precordial electrodes. 4 limb electrodes will be added for the frontal leads. Thus, the HD and 12-lead ECGs will be obtained simultaneously.</description>
    <arm_group_label>Proven or suspected arrhythmias group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient managed at the Bordeaux University Hospital for assessment of documented&#xD;
             severe ventricular arrhythmia (VF, sudden resuscitated death) or suspected (syncope,&#xD;
             family history of sudden death, ECG or Holter abnormality) or impaired ventricular&#xD;
             conduction, OR&#xD;
&#xD;
          -  Patients managed for prophylactic ventricular defibrillator implantation, according to&#xD;
             international recommendations: Heart disease with ejection fraction &lt; 35%, heart&#xD;
             disease with sustained ventricular tachycardia, cardiomyopathies with high rhythmic&#xD;
             risk,&#xD;
&#xD;
          -  Women of childbearing age with effective contraception.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients under 14 years old,&#xD;
&#xD;
          -  pregnant or nursing woman.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michel HAÏSSAGUERRE, MD-PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Bordeaux</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michel HAÏSSAGUERRE, MD-PhD</last_name>
    <phone>(0)5 57 65 64 71</phone>
    <phone_ext>+33</phone_ext>
    <email>michel.haissaguerre@chu-bordeaux.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aude CATHALA</last_name>
    <email>aude.cathala@chu-bordeaux.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Bordeaux University Hospital</name>
      <address>
        <city>Pessac</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michel HAÏSSAGUERRE, MD-PhD</last_name>
      <phone>(0)5 57 65 64 71</phone>
      <phone_ext>+33</phone_ext>
      <email>michel.haissaguerre@chu-bordeaux.fr</email>
    </contact>
    <contact_backup>
      <last_name>Aude CATHALA</last_name>
      <email>aude.cathala@chu-bordeaux.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Frédéric SACHER, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michel HAÏSSAGUERRE, MD-PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Josselin DUCHATEAU, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Romain TIXIER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hugo MARCHAND, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>June 4, 2021</study_first_submitted>
  <study_first_submitted_qc>June 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 10, 2021</study_first_posted>
  <last_update_submitted>June 4, 2021</last_update_submitted>
  <last_update_submitted_qc>June 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Signal Averaging ECG</keyword>
  <keyword>Cardiac electrophysiology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

